BioAtla (BCAB) Return on Sales [ROS] (2020 - 2026)
BioAtla (BCAB) posted Return on Sales [ROS] of 3.49% for Q2 2026, up 539.42 percentage points from -535.92% a year earlier.
Powered by 
Analysis
BioAtla (BCAB) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at BioAtla was -377.94%, up 157.98 percentage points year-over-year; for FY2025, it came in at -2965.25%, down 2293.04 percentage points from FY2024.
- Annual Return on Sales [ROS] shows a five-year change of +4050.83 percentage points (FY2020 to FY2025).
- In prior years, BioAtla's Return on Sales [ROS] was -672.21% in FY2024 and -38576.00% in FY2021 (-31559.92 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Sales [ROS] in data going back to Q1 2020.
- On a year-over-year basis, Return on Sales [ROS] increased in four of the last five quarters, with an average year-over-year change of +10777.03 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | BioAtla | 2.99 Mn | -15.95 Mn | - | 3.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.49% |
| Dec 31, 2025 | -462.75% |
| Sep 30, 2025 | -602.67% |
| Jun 30, 2025 | -535.92% |
| Dec 31, 2024 | -621.37% |
| Sep 30, 2024 | -102.45% |
| Jun 30, 2024 | -2,441.33% |
| Sep 30, 2023 | -51,884.40% |
| Dec 31, 2021 | -38,576.00% |
| Sep 30, 2021 | -35,762.80% |
| Jun 30, 2021 | -12,184.00% |
| Mar 31, 2021 | -14,055.00% |
| Dec 31, 2020 | -7,016.08% |
| Sep 30, 2020 | -5,343.33% |
| Jun 30, 2020 | -2,378.95% |
| Mar 31, 2020 | -1,246.07% |
API Access
BioAtla Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BCAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "BCAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BCAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();